TSN and liver dysplastic nodule: Combined with the results of GO and KEGG enrichment analysis, we presumed that a potential mechanism for TSN treatment in DN may be to reduce ECM deposition in the kidneys of DN patients by modulating levels of growth factors and chemokines, improving cellular stress and inflammation, and inhibiting EMT-induced cell proliferation.